RYR2 and cervical carcinoma: Similar results were reported by Bennett and colleagues, who demonstrated that neither ryanodine nor caffeine (RyR agonist) elicited a measurable RyR2-mediated Ca2+ transient in cervical cancer epithelial cell line HeLa, suggesting aberrant functional properties of RyR2s in the survival of cancer cells [138].